Clinical trial Recruiting at 1 site Observational Ages 40 to 90

Exploring biomarkers for cognitive disorders in China

Official title: Cohort Study on Biomarkers of Cognitive Disorders in China

Run by Xuanwu Hospital, Beijing · NCT06419101 · Data updated 2026-11-12

This study is trying to find early signs of dementia by following 3,000 people in China who have different stages of memory problems to see how their condition changes over time.

Quick facts

Study typeObservational
Ages40 Years to 90 Years
SexAll
Enrollment3000 (estimated)
SponsorXuanwu Hospital, Beijing
Academic / other
Locations1 site (Beijing)
StatusRecruiting
StartedMay 30, 2024
Main results expectedMay 10, 2034
Study endsMay 10, 2035
Registry record updatedNovember 14, 2024
Trial IDNCT06419101 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are Chinese individuals aged 40 to 90 who exhibit signs of cognitive decline.

Probably not a fit

Patients with severe cognitive impairment or other neurological diseases that could confound results may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to establish a large-scale dementia cohort in China by enrolling 3000 patients with pre-dementia stages and various dementia subtypes. It will collect comprehensive data, including demographics, clinical symptoms, neuropsychological assessments, neuroimaging, and biological samples. Participants will undergo annual follow-ups to monitor changes in their cognitive status, allowing researchers to compare clinical phenotypes and identify potential biomarkers for early diagnosis and progression of dementia. The study seeks to address the lack of longitudinal data on cognitive decline in the Chinese population.

Why it matters

Potential benefit: If successful, this study could lead to improved diagnostic methods and early intervention strategies for dementia, enhancing patient outcomes.

How similar studies have gone: Other studies have successfully established dementia cohorts and identified biomarkers, suggesting that this approach has potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Male or female patients aged ≥40 and ≤90years;
* Chief complaint or others describe a cognitive decline;
* Ability to communicate in Chinese;
* The patients and their families were informed and signed the informed consent.

Exclusion Criteria:

* MMSE\<10;
* There are other neurological diseases that can cause brain dysfunction (such as depression, brain tumors, Parkinson's disease, metabolic encephalopathy, encephalitis, multiple sclerosis, epilepsy, traumatic brain injury, normal intracranial pressure hydrocephalus, etc.);
* There are other systemic diseases that can cause cognitive impairment (such as hepatic insufficiency, renal insufficiency, Thyroid dysfunction, severe anemia, folic acid or vitamin B12 deficiency, syphilis, HIV infection, alcohol and drug abuse, etc.);
* Suffering from a disease that cannot cooperate with the completion of cognitive examination;
* There are contraindications to nuclear magnetic resonance;
* There is mental and neurodevelopmental delay;
* Refuse to draw blood;
* Refuse to sign the informed consent.

Where it's running

  • Capital Medical University Xuanwu Hospital
    Beijing, China
    Recruiting

Study contacts

  • Principal investigator: Cuibai Wei — Xuan Wu Hospital of Capital Medical University, Beijing, China, 100053
  • Study coordinator: Cuibai Wei
  • Email: weicb@xwhosp.org
  • Phone: 83198319

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.